Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $10 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DVA perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical care facilities industry. DVA is a trusted leader known for quality care and innovation in kidney care. Its integrated approach offers services from diagnosis to transplant support,...

Fundamentals

See More
  • Market Capitalization, $K 9,973,908
  • Shares Outstanding, K 66,800
  • Annual Sales, $ 13,643 M
  • Annual Income, $ 746,800 K
  • EBIT $ 2,759 M
  • EBITDA $ 3,474 M
  • 60-Month Beta 0.94
  • Price/Sales 0.73
  • Price/Cash Flow 6.90
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 37.95% (+2.21%)
  • Historical Volatility 31.79%
  • IV Percentile 63%
  • IV Rank 40.15%
  • IV High 57.57% on 04/08/25
  • IV Low 24.78% on 08/22/25
  • Expected Move (DTE 27) 9.95 (6.66%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8,760
  • Volume Avg (30-Day) 1,425
  • Put/Call OI Ratio 1.41
  • Today's Open Interest 36,737
  • Open Int (30-Day) 34,737
  • Expected Range 139.37 to 159.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.41
  • Number of Estimates 2
  • High Estimate 2.50
  • Low Estimate 2.32
  • Prior Year 2.00
  • Growth Rate Est. (year over year) +20.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.00 +2.27%
on 02/25/26
159.42 -6.34%
on 03/02/26
-1.42 (-0.94%)
since 02/20/26
3-Month
101.00 +47.83%
on 01/14/26
159.42 -6.34%
on 03/02/26
+34.11 (+29.61%)
since 12/19/25
52-Week
101.00 +47.83%
on 01/14/26
159.42 -6.34%
on 03/02/26
+0.30 (+0.20%)
since 03/20/25

Most Recent Stories

More News
DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.

XLV : 145.33 (-0.87%)
FMS : 21.64 (-2.13%)
DVA : 149.31 (-0.30%)
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

Disclaimer: The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and...

DVA : 149.31 (-0.30%)
3 Unpopular Stocks That Fall Short

3 Unpopular Stocks That Fall Short

FCN : 174.20 (+2.85%)
DIN : 28.42 (-2.67%)
DVA : 149.31 (-0.30%)
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

DENVER , Feb. 24, 2026 /PRNewswire/ --  DaVita Inc.  (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason,...

DVA : 149.31 (-0.30%)
1 Momentum Stock to Keep an Eye On and 2 We Ignore

1 Momentum Stock to Keep an Eye On and 2 We Ignore

WDFC : 213.83 (-0.89%)
SYY : 81.33 (-0.42%)
DVA : 149.31 (-0.30%)
3 S&P 500 Stocks We Find Risky

3 S&P 500 Stocks We Find Risky

MCHP : 62.97 (-0.51%)
PKG : 202.73 (-0.81%)
DVA : 149.31 (-0.30%)
DaVita Stock: Is Wall Street Bullish or Bearish?

Are Wall Street analysts bullish or bearish on DaVita’s stock after its fourth-quarter earnings?

XLV : 145.33 (-0.87%)
$SPX : 6,506.48 (-1.51%)
DVA : 149.31 (-0.30%)
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call

DVA : 149.31 (-0.30%)
Stocks Tumble on AI Disruption Fears

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.55%. March E-mini...

TER : 290.83 (-3.83%)
AMAT : 357.06 (-0.04%)
TRIP : 9.35 (+0.65%)
AVGO : 310.51 (-2.92%)
INTU : 455.56 (+0.07%)
HL : 17.24 (-2.10%)
CDE : 17.67 (-3.28%)
MRK : 114.18 (-0.02%)
EXPE : 235.18 (-1.77%)
FN : 506.27 (-6.38%)
TRI : 93.44 (+0.19%)
ADM : 66.17 (-3.60%)
Why Is DaVita (DVA) Stock Rocketing Higher Today

Why Is DaVita (DVA) Stock Rocketing Higher Today

DVA : 149.31 (-0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 155.19
2nd Resistance Point 153.84
1st Resistance Point 151.57
Last Price 149.31
1st Support Level 147.96
2nd Support Level 146.61
3rd Support Level 144.34

See More

52-Week High 159.42
Last Price 149.31
Fibonacci 61.8% 137.10
Fibonacci 50% 130.21
Fibonacci 38.2% 123.32
52-Week Low 101.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.